Big Gain For Sophiris Bio, Inc.

Fri 13 Mar 20 at 05:30 PM
Big Gain For Sophiris Bio, Inc.

Sophiris Bio, Inc. (SPHS:NASDAQ) rocketted at $0.18, a gain of 80%. On Thu 12 Mar 20, SPHS:NASDAQ hit a New 2-Week Low of $0.1. The stock appeared on our News Catalysts scanner on Wed 11 Mar 20 at 08:47 AM in the 'INVESTOR UPDATE' category. From Thu 27 Feb 20, the stock recorded 30.00% Up Days and 27.27% Green Days

About Sophiris Bio, Inc. (SPHS:NASDAQ)

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.